Brief: XORTX Therapeutics Provides Update On FDA Type B Meeting Request
30/04/2025 12:12
April 30 (Reuters) - XORTX Therapeutics Inc XRTX.V: XORTX PROVIDES UPDATE ON FDA TYPE B MEETING REQUEST XORTX THERAPEUTICS INC - EXPECTS TO FILE GOUT NDA IN H1 2026 Source text: ID:nGNX2D2C7m Further company coverage: XRTX.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering